Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00261391 · ClinicalTrials.gov registry record · Phase 1
Phase I Drug Trial for S/E of Marimastat in Disabling Malformations When no Other Options.
A Phase 1 study of Vascular Anomalies, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- Phase 1
- Development phase
- 9
- Enrollment target
- 1
- Study location
NCT00261391: Completed Phase 1 study of Vascular Anomalies, sponsored by Boston Children's Hospital.
NCT00261391 is a Phase 1 study of Vascular Anomalies that has completed, run by Boston Children's Hospital. The registered enrollment target is 9 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00261391, a Phase 1 study of Vascular Anomalies, has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 9 participants
- Enrollment target
- 1
- Study location
Study Summary
3 patients were enrolled in each of 3 study cohorts. There three cohorts were given differing, incrementally larger doses of this phase I drug. The same safety measures are being obtained on all patients. Efficacy measures were individualized as enrolllees do not have the same underlying vascular anomaly. The study is structured to include a 24 month drug-phase and a 24 month follow-up phase. The study is now closed to enrollment.
Conditions Studied
Interventions
- DRUG Marimastat
Study Locations (1)
Massachusetts
- Childrens Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2000-10 |
| Est. Completion | 2007-10 |
| Phase | Phase 1 |
What the finished NCT00261391 record still lists
NCT00261391 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (85% lower).
The record links to 1 condition, with Vascular Anomalies appearing as the primary indexed condition, and to 1 intervention - of which Marimastat is the first listed.
NCT00261391 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00261391 about?
NCT00261391 is a clinical study titled "Phase I Drug Trial for S/E of Marimastat in Disabling Malformations When no Other Options.". 3 patients were enrolled in each of 3 study cohorts. There three cohorts were given differing, incrementally larger doses of this phase I drug. The same safety measures are being obtained on all patients. Efficacy measures were individualized as enrolllees do not have the same underlying vascular an...
What is the current status of trial NCT00261391?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 9 participants. The study started on 2000-10. Estimated completion is 2007-10.
What conditions does trial NCT00261391 study?
This clinical trial studies the following conditions: Vascular Anomalies.
What interventions are being tested in trial NCT00261391?
The interventions under investigation include: Marimastat (DRUG).
Who is sponsoring clinical trial NCT00261391?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00261391 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00261391's enrollment target sits among peer trials
9 1955th of 2000 higher than 42 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia